NIH Archive — Page 47 of 93
-
June 12, 2017
Repriming replication roadblocks
New findings shed light on how enzymes that replicate DNA skip over mutations that might cause cancer and restart DNA synthesis further away. -
June 9, 2017
Flip side of gut protection
Vanderbilt investigators report that dysregulation of certain immune cells in the intestines may lead to inflammation and disease. -
June 8, 2017
VUMC lands renewal of Clinical and Translational Science Award
Vanderbilt University Medical Center (VUMC) has competed successfully for a second renewal of its Clinical and Translational Science Award (CTSA) by the National Institutes of Health (NIH). -
June 8, 2017
NIDDK renews Vanderbilt’s diabetes research grant
The Vanderbilt Diabetes Research and Training Center (VDRTC) is celebrating its 44th year of operation with a five-year competitive renewal of its $9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH). -
May 26, 2017
Preserving NIH’s Fogarty International Center crucial for global health efforts
This week Douglas Heimburger, M.D., M.S., professor of Medicine at Vanderbilt, joined a growing chorus calling for preservation of the Fogarty International Center of the National Institutes of Health (NIH). -
May 18, 2017
Oxidative stress in tumors
Vanderbilt investigators have developed a new method for measuring oxidative stress in human tumors, which provides insight into cancer development. -
May 15, 2017
RSV-HRV viral interference
RSV infection reduces the risk of infection with human rhinovirus, which could have implications for vaccine development and prevention strategies for viral respiratory tract infections in infants.